管理腔腔皮菌病 专家意见 改善患者的治疗结果
Fariba M Donovan1, George R Thompson2, Janis E Blair3
1Valley Fever Center for Excellence, University of Arizona School of Medicine, Tucson, AZ; Division of Infectious Diseases, Department of Internal Medicine, University of Arizona School of Medicine, Tucson, AZ; University of Arizona, Tucson, AZ; The BIO5 Institute, University of Arizona, Tucson, AZ.
Chest
|December 15, 2024
概括
型菌病是一个日益增长的全球威胁. 本文重点介绍了空腔病变的管理,这是这种真菌感染的严重长期并发症,因为缺乏明确的治疗指南.
科学领域:
- 菌类学 菌类学是指菌类学.
- 传染性疾病 传染性疾病
- 肺部病理学 肺部病理学
背景情况:
- 由Coccidioides真菌引起的Coccidioidomycosis是一个日益严重的国家和全球的健康问题.
- 肺性菌菌病影响了30%的暴露个体,其中5%患有严重或扩散性疾病.
- 长期的肺部继发症,包括腔腔病变,发生在5-15%的病例中,造成诊断挑战和严重的患者负担.
研究的目的:
- 为了提供一个全面的评估和管理的洞穴病变在coccidioidomycosis.com的综合描述.
- 解决这些长期肺部并发症缺乏明确的管理策略的问题.
- 提供来自多学科专家组的建议.
主要方法:
- 文献综述和当前实践指南的综合.
- 多学科专家共识的发展.
- 专注于评估,表现,以及腔菌菌病的并发症.
主要成果:
- 腔病变可模仿恶性瘤或结核病,使诊断复杂化.
- 现有的文献和指导方针为管理这些腔腔病变提供了有限的明确策略.
- 该报告旨在巩固专家建议,以管理这种特殊的并发症.
结论:
- 腔腔形形形形形形形形形形形形形形形形形形形形形形形形形形形形形形形形形形形形形形形形形形形形
- 多学科的方法对于有效的评估和治疗至关重要.
- 需要进一步的研究和标准化的指导方针来改善患者的治疗结果.
更多相关视频
相关概念视频
Cystic Fibrosis: Management
139
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
139
Pleural Effusion II: Symptoms and Management
154
Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
154
Pulmonary Tuberculosis V
170
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
170
COPD: Management Using Bronchodilators and Corticosteroids
177
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
177
Pneumonia IV: Management
298
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
298
Healthcare Associated Infections II: Preventive Measures
2.4K
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
2.4K


